Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Sermorelin was approved for treating growth hormone deficiency in children, though the manufacturer pulled it from the market in 2008 for commercialnot safetyreasons
Based on Phase 2 clinical trial data published in the New England Journal of Medicine (2023), retatrutide shares a side-effect profile broadly consistent with other GLP-1 receptor agonist class medicines, though the addition of glucagon receptor agonism may introduce some distinct effects
doi:10.3389/fendo.2021.790405 Garvey WT, Blher M, Osorto Contreras CK, et al
Identifying outlier prescribing
Syringes are smaller, take up a lot less space, and have less waste
Improved Metabolic Health: It has been shown to improve insulin sensitivity, reduce blood sugar levels, and lower HbA1c, making it beneficial for individuals with type 2 diabetes or prediabetes
